ISRG
Intuitive Surgical insider trading
Health Care · Heavy selling
Close · Oct 5, 2026
$406.48
-9.6% over 12 months
Share price and insider trades
ISRG closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$93.4M
Insiders buying0
Insiders selling12
Valuation, profit and volume
P/E (trailing)n/aSector median 24.5
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.6×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Intuitive Surgical insiders reported open-market purchases totaling $0, while 12 insiders reported sales totaling $93.4M. 83 of 83 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales. 139 grants, option exercises and tax withholdings are not shown.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 16SEC | Fredrik WidmanVp Corporate Controller | Sell Plan | 546 | $374.44 | $204K | +8.6% | — |
| Sep 16SEC | Fredrik WidmanVp Corporate Controller | Sell Plan | 543 | $374.44 | $203K | +8.6% | — |
| Sep 11SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 25 | $365.79 | $9K | +11.1% | — |
| Sep 11SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 23 | $347.66 | $8K | +16.9% | — |
| Sep 9SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 46 | $361.23 | $17K | +12.5% | — |
| Sep 9SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 23 | $350.20 | $8K | +16.1% | — |
| Aug 21SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 77 | $396.37 | $31K | +2.6% | — |
| Aug 21SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 77 | $375.57 | $29K | +8.2% | — |
| Aug 19SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 77 | $394.26 | $30K | +3.1% | — |
| Aug 19SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 77 | $394.00 | $30K | +3.2% | — |
| Aug 19SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 77 | $390.67 | $30K | +4.0% | — |
| Aug 12SEC | Gary S GuthartDirector | Sell Plan | 10,000 | $400.00 | $4.0M | +1.6% | — |
| Aug 11SEC | Amy L LaddDirector | Sell Plan | 400 | $379.00 | $152K | +7.3% | — |
| Aug 11SEC | Amy L LaddDirector | Sell Plan | 72 | $393.10 | $28K | +3.4% | — |
| Aug 10SEC | Gary LoebGeneral Counsel | Sell Plan | 400 | $379.00 | $152K | +7.3% | — |
| Jul 31SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 28 | $351.00 | $10K | +15.8% | — |
| Jul 31SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 28 | $346.83 | $10K | +17.2% | — |
| Jul 29SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 28 | $365.58 | $10K | +11.2% | — |
| Jul 29SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 28 | $360.21 | $10K | +12.8% | — |
| Jul 29SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 28 | $344.00 | $10K | +18.2% | — |
| Jun 12SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 25 | $414.13 | $10K | -1.8% | — |
| Jun 12SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 23 | $412.16 | $9K | -1.4% | — |
| Jun 10SEC | Gary LoebGeneral Counsel | Sell Plan | 400 | $424.14 | $170K | -4.2% | — |
| Jun 10SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 23 | $424.14 | $10K | -4.2% | — |
| Jun 10SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 23 | $421.13 | $10K | -3.5% | — |
| Jun 10SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 23 | $420.12 | $10K | -3.2% | — |
| Jun 2SEC | Iman JeddiSvp & Gm Da Vinci Platforms & | Sell Plan | 5,625 | $420.55 | $2.4M | -3.3% | — |
| May 22SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 18 | $446.04 | $8K | -8.9% | — |
| May 22SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 18 | $439.80 | $8K | -7.6% | — |
| May 20SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 18 | $440.70 | $8K | -7.8% | — |
| May 20SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 18 | $440.38 | $8K | -7.7% | — |
| May 20SEC | Mark BrosiusEvp & Chief Mfg And Supply Cha | Sell Plan | 18 | $422.47 | $8K | -3.8% | — |
| May 11SEC | Gary LoebGeneral Counsel | Sell Plan | 400 | $446.95 | $179K | -9.1% | — |
| Apr 29SEC | Amy L LaddDirector | Sell Plan | 500 | $473.46 | $237K | -14.1% | — |
| Apr 29SEC | Amy L LaddDirector | Sell Plan | 119 | $463.50 | $55K | -12.3% | — |
| Mar 11SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 105 | $493.95 | $52K | -17.7% | — |
| Mar 10SEC | Mark BrosiusSvp & Chief Mfg And Supply Cha | Sell Plan | 648 | $490.19 | $318K | -17.1% | — |
| Mar 10SEC | Mark BrosiusSvp & Chief Mfg And Supply Cha | Sell Plan | 645 | $485.01 | $313K | -16.2% | — |
| Mar 5SEC | Mark BrosiusSvp & Chief Mfg And Supply Cha | Sell Plan | 2,362 | $498.68 | $1.2M | -18.5% | — |
| Mar 5SEC | Mark BrosiusSvp & Chief Mfg And Supply Cha | Sell Plan | 648 | $495.20 | $321K | -17.9% | — |
| Mar 5SEC | Mark BrosiusSvp & Chief Mfg And Supply Cha | Sell Plan | 648 | $488.10 | $316K | -16.7% | — |
| Mar 3SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 4,728 | $487.18 | $2.3M | -16.6% | — |
| Mar 3SEC | Fredrik WidmanVp Corporate Controller | Sell Plan | 249 | $499.71 | $124K | -18.7% | — |
| Mar 3SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 125 | $492.59 | $62K | -17.5% | — |
| Mar 3SEC | Fredrik WidmanVp Corporate Controller | Sell Plan | 118 | $487.18 | $57K | -16.6% | — |
| Mar 2SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 2,345 | $499.71 | $1.2M | -18.7% | — |
| Feb 27SEC | Patricia L WadorsSvp Chief Human Resources Offi | Sell Plan | 220 | $499.71 | $110K | -18.7% | — |
| Feb 11SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 421 | $494.96 | $208K | -17.9% | — |
| Feb 11SEC | Fredrik WidmanVp Corporate Controller | Sell Plan | 133 | $494.96 | $66K | -17.9% | — |
| Feb 11SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 105 | $494.65 | $52K | -17.8% | — |
| Jan 30SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 126 | $520.02 | $66K | -21.8% | — |
| Jan 28SEC | Gary S GuthartDirector | Sell Plan | 24,500 | $530.10 | $13.0M | -23.3% | — |
| Jan 28SEC | Gary S GuthartDirector | Sell Plan | 1,400 | $531.53 | $744K | -23.5% | — |
| Jan 28SEC | Gary S GuthartDirector | Sell Plan | 1,400 | $531.52 | $744K | -23.5% | — |
| Jan 28SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 125 | $532.61 | $67K | -23.7% | — |
| Jan 28SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 105 | $532.61 | $56K | -23.7% | — |
| Dec 17SEC | Mark BrosiusSee Remarks | Sell Plan | 464 | $548.49 | $254K | -25.9% | — |
| Dec 17SEC | Mark BrosiusSee Remarks | Sell Plan | 312 | $547.36 | $171K | -25.7% | — |
| Dec 15SEC | Mark BrosiusSvp & Chief Mfg And Supply Cha | Sell Plan | 4,500 | $547.36 | $2.5M | -25.7% | — |
| Dec 15SEC | Mark BrosiusSvp & Chief Mfg And Supply Cha | Sell Plan | 464 | $548.49 | $254K | -25.9% | — |
| Dec 10SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 104 | $559.90 | $58K | -27.4% | — |
| Dec 2SEC | Gary S GuthartChair | Sell Plan | 22,806 | $570.89 | $13.0M | -28.8% | — |
| Dec 2SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 125 | $568.99 | $71K | -28.6% | — |
| Nov 13SEC | Henry L CharltonEvp & Chief Commercial And Mkt | Sell Plan | 4,731 | $580.00 | $2.7M | -29.9% | — |
| Nov 13SEC | Henry L CharltonEvp & Chief Commercial And Mkt | Sell Plan | 2,901 | $580.00 | $1.7M | -29.9% | — |
| Nov 13SEC | Henry L CharltonEvp & Chief Commercial And Mkt | Sell Plan | 2,898 | $580.00 | $1.7M | -29.9% | — |
| Nov 13SEC | Henry L CharltonEvp & Chief Commercial And Mkt | Sell Plan | 2,565 | $580.00 | $1.5M | -29.9% | — |
| Nov 13SEC | Craig H BarrattDirector | Sell Plan | 750 | $580.00 | $435K | -29.9% | — |
| Nov 13SEC | Henry L CharltonEvp & Chief Commercial And Mkt | Sell Plan | 636 | $580.00 | $369K | -29.9% | — |
| Nov 12SEC | Brian Edward MillerEvp & Chief Digital Officer | Sell Plan | 2,202 | $575.00 | $1.3M | -29.3% | — |
| Nov 12SEC | Brian Edward MillerEvp & Chief Digital Officer | Sell Plan | 1,298 | $575.00 | $746K | -29.3% | — |
| Nov 12SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 105 | $560.00 | $59K | -27.4% | — |
| Nov 6SEC | Fredrik WidmanVp Corporate Controller | Sell Plan | 1,908 | $550.00 | $1.0M | -26.1% | — |
| Nov 6SEC | Fredrik WidmanVp Corporate Controller | Sell Plan | 159 | $550.00 | $87K | -26.1% | — |
| Oct 29SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 5,030 | $548.43 | $2.8M | -25.9% | — |
| Oct 29SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 1,379 | $548.43 | $756K | -25.9% | — |
| Oct 29SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 1,153 | $548.43 | $632K | -25.9% | — |
| Oct 29SEC | Myriam CuretEvp & Chief Medical Officer | Sell Plan | 125 | $543.00 | $68K | -25.1% | — |
| Oct 27SEC | Gary S GuthartChair | Sell Plan | 28,800 | $547.56 | $15.8M | -25.8% | — |
| Oct 27SEC | David J. RosaCEO | Sell Plan | 24,500 | $547.55 | $13.4M | -25.8% | — |
| Oct 27SEC | Craig H BarrattDirector | Sell Plan | 2,193 | $548.01 | $1.2M | -25.8% | — |
| Oct 27SEC | Gary S GuthartChair | Sell Plan | 1,400 | $546.35 | $765K | -25.6% | — |
| Oct 27SEC | Gary S GuthartChair | Sell Plan | 1,400 | $546.18 | $765K | -25.6% | — |
Insiders at Intuitive Surgical
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Gary S GuthartDirector | — | $48.8M | Aug 12, 2026 | — |
| David J. RosaCEO | — | $13.4M | Jul 13, 2026 | — |
| Myriam CuretEvp & Chief Medical Officer | — | $8.4M | Mar 11, 2026 | — |
| Henry L CharltonEvp & Chief Commercial And Mkt | — | $8.0M | Mar 2, 2026 | — |
| Mark BrosiusEvp & Chief Mfg And Supply Cha | — | $5.9M | Sep 11, 2026 | — |
| Iman JeddiSvp & Gm Da Vinci Platforms & | — | $2.4M | Jun 2, 2026 | — |
| Brian Edward MillerEvp & Chief Digital Officer | — | $2.0M | Nov 12, 2025 | — |
| Fredrik WidmanVp Corporate Controller | — | $1.8M | Sep 16, 2026 | — |
| Craig H BarrattDirector | — | $1.6M | Apr 30, 2026 | — |
| Gary LoebGeneral Counsel | — | $500K | Aug 10, 2026 | — |
| Amy L LaddDirector | — | $472K | Aug 11, 2026 | — |
| Patricia L WadorsSvp Chief Human Resources Offi | — | $110K | Feb 27, 2026 | — |
| Jami K NachtsheimDirector | — | — | Apr 30, 2026 | — |
| Lewis ChewDirector | — | — | Apr 30, 2026 | — |
| Joseph C BeeryDirector | — | — | Apr 30, 2026 | — |
| Amal M JohnsonDirector | — | — | Apr 30, 2026 | — |
| Keith R LeonardDirector | — | — | Apr 30, 2026 | — |
| Sreelakshmi KolliDirector | — | — | Apr 30, 2026 | — |
| Monica P ReedDirector | — | — | Apr 30, 2026 | — |
| Jamie SamathCFO | — | — | Mar 2, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
Common questions about ISRG insiders
Are Intuitive Surgical insiders buying ISRG stock?
In the past 12 months, 0 insiders reported open-market purchases of ISRG worth $0.
Are Intuitive Surgical insiders selling ISRG stock?
12 insiders reported sales worth $93.4M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.